Developer docs
API playgroundTry for free, no card

Search company profiles

JuneBrain

Full company profile

uuid0000cpf

Namestring
JuneBrain
Legal namestring
JuneBrain Inc.
Websiteurl
junebrain.com
Company typeenum
Private
Founded yearint
2017
Short descriptiontext

JuneBrain Inc. is a Baltimore-based medical technology company developing portable AI-powered OCT imaging hardware and deep learning segmentation software for remote monitoring of neurological and retinal diseases, serving clinical research organizations, reading centers, and neurology providers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBaltimore, United States
HQ citystring
Baltimore
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
retinal imaging devices, OCT analysis software, neurological disease monitoring, AI medical imaging, clinical research OCT
Industry2 codes
PRIMARYHLAHAJAB
Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLALAGAC
Neurology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Ophthalmic Medical Imaging Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Software Licensing (JDAe)
TypeSubscription Recurring
Description

Annual per-seat license for JDAe automated segmentation software at $6K/year. Customers can test with one free analysis before committing. Pricing is transparent and subscription-based.

junebrain.com
2Software Licensing (JAM)
TypeSubscription Recurring
Description

Annual per-seat license for JAM manual correction tool at $3.5K/year. Can be bundled with JDAe for $8.5K/year.

junebrain.com
3Bundled Software License
TypeSubscription Recurring
Description

Bundle of both JDAe and JAM tools at $8.5K/year, offering savings of $1K compared to separate purchases.

junebrain.com
4Neuro-i SS-OCT Device Sales
TypeHardware Sales
Description

Hardware sales of the Neuro-i SS-OCT portable retinal imaging device for point-of-care settings. The company is pursuing FDA clearance for early commercial launch.

junebrain.com
5Reading Center Services
TypeSubscription Recurring
Description

OCT analysis services for clinical research, including both fixed price and subscription options for research groups and reading centers.

junebrain.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Pricing details3 tiers
1JDAe - Automated segmentation annual license
ModelSubscriptionBilling cadenceAnnual
Notes

$6,000 per year, per seat. Includes automated OCT segmentation with AI-based analysis, cross-vendor compatibility (Cirrus, Spectralis, Neuro-i), structured outputs (per-layer thickness, ETDRS sectorization, PDF report + CSV), and human-in-the-loop QC capabilities.

junebrain.com
2JAM - Manual correction annual license
ModelSubscriptionBilling cadenceAnnual
Notes

$3,500 per year, per seat. Includes manual correction of layer boundaries, pathological region annotation, and JSON export with full audit trail.

junebrain.com
3Bundle - Both JDAe and JAM tools
ModelSubscriptionBilling cadenceAnnual
Notes

$8,500 per year (save $1,000 vs. separate purchases). Includes both automated segmentation and manual correction tools for complete workflow.

junebrain.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1Neuro-i SS-OCT
Description

Wearable AI-powered retinal imaging platform for point-of-care OCT imaging in neurology, primary care, and community health settings.

junebrain.com
+1 more record
Core offering1 text field

JuneBrain develops telehealth OCT (Optical Coherence Tomography) devices and AI-powered software for remote monitoring of neurological and retinal diseases. Its flagship product, the Neuro-i SS-OCT, is a portable wearable retinal imaging headset designed for use by minimally trained personnel in neurology, primary care, and community health settings. The company also sells JDAe (automated deep learning segmentation software) and JAM (manual correction tool) on annual per-seat licenses, and provides the Reading Center OCT analysis service for clinical research organizations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

JuneBrain develops a telehealth OCT device and AI software platform for remote monitoring of neurological and retinal diseases. The core product is the Neuro-i SS-OCT, a portable wearable retinal imaging headset that enables point-of-care OCT imaging in non-traditional settings. Supporting the hardware is a software portfolio comprising JDAe (AI-driven automated segmentation engine) and JAM (manual correction tool) for analyzing OCT data from multiple device vendors. The Reading Center service provides outsourced quantitative OCT analysis for clinical research. The platform is designed for investigational use only.

Product and service4 records
1Neuro-i SS-OCT
CategoryOphthalmic medical imaging hardware
Description

A portable, wearable AI-powered retinal imaging headset using swept-source OCT technology for point-of-care use in neurology, primary care, and community health settings. Designed for minimally trained users with automated image acquisition.

2JDAe (JuneBrain Deep Learning Engine)
CategoryMedical imaging AI software
Description

AI-based automated segmentation software that reads Cirrus, Spectralis, and Neuro-i OCT data; segments 8+ retinal layers automatically; measures average thickness for 9 standard ETDRS subfields; and exports deterministic results in PDF report and CSV formats. Licensed annually per seat at $6,000/year.

3JAM (JuneBrain Annotation Module)
CategoryMedical imaging AI software
Description

Manual correction tool for OCT segmentation that allows users to correct existing layer boundaries, annotate pathological regions, and export corrected data in JSON format. Includes human-in-the-loop QC and full audit trail for trial-grade data. Licensed annually per seat at $3,500/year, or bundled with JDAe at $8,500/year.

4Reading Center
CategoryClinical research services
Description

Outsourced quantitative OCT analysis service for clinical research organizations and reading centers. Provides fast, automated deep-learning-based analysis, reliable segmentation of up to 8 retinal layers, quality control by experienced clinicians, and both fixed-price and subscription pricing options.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierSupportingTypeImplementation/ SI/ Consulting PartnerAnnounced on2024-09-08
Description

Compliance Group collaborated with JuneBrain on the MDIC AMCH program grant to implement advanced design control and risk management technology for quality management system modernization.

2Siemens Digital Industries
Strategic tierSupportingTypeTechnology or IntegrationAnnounced on2024-09-08
Description

Siemens Digital Industries collaborated with JuneBrain on the MDIC AMCH program grant to implement advanced design control and risk management technology, supporting FDA clearance efforts.

medicalbuyer.co.in
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Manufacturer of the Spectralis OCT platform, one of the dominant clinical OCT systems whose data JuneBrain's JDAe reads; a direct peer in retinal imaging hardware and adjacent in OCT analysis software.

2Carl Zeiss Meditec
TypeDirect peer
Description

Maker of the Cirrus OCT platform, the other dominant OCT system integrated with JDAe; competes with JuneBrain in ophthalmic imaging and increasingly in AI-driven analysis.

TypeDirect peer
Description

Developer of Avanti and Solix OCT/ OCTA devices, a direct peer in retinal OCT hardware pursuing point-of-care and AI-enabled imaging workflows similar to Neuro-i.

TypeDirect peer
Description

Major ophthalmic imaging vendor (Maestro2, Triton OCT) competing in the same OCT hardware category and pushing AI/portable features relevant to JuneBrain's roadmap.

TypeDirect peer
Description

Home-based OCT monitoring service for retinal disease using AI-driven analysis; highly comparable business model to JuneBrain's Reading Center plus Neuro-i concept of remote, frequent retinal monitoring.

TypeDirect peer
Description

Maker of iCare EIDON and DRI OCT Triton/Atlantis systems, competing in clinical and emerging portable OCT segments and pursuing primary-care adoption analogous to Neuro-i.

TypeDirect peer
Description

AI platform for OCT and fundus image analysis used by ophthalmology clinics and clinical research; the closest direct competitor to JDAe/JAM in OCT segmentation SaaS.

TypeEmerging player
Description

Specialist in AI-based OCT layer segmentation and analysis tools for research and clinical use; competes with JuneBrain's JDAe/JAM in the OCT segmentation software category.

TypeEmerging player
Description

AI health-screening company using retinal imaging (including OCT) to predict systemic and neurodegenerative disease risk; overlaps with JuneBrain's MS/neurology use cases via AI-on-retina.

TypeOthers
Description

FDA-cleared autonomous AI diagnostic platform (IDx-DR) for diabetic retinopathy; comparable as a regulated AI-imaging diagnostics company navigating similar regulatory and clinical-adoption dynamics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds13 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JuneBrain

Ophthalmic Medical Imaging Softwarejunebrain.com

JuneBrain Inc. is a Baltimore-based medical technology company developing portable AI-powered OCT imaging hardware and deep learning segmentation software for remote monitoring of neurological and retinal diseases, serving clinical research organizations, reading centers, and neurology providers.

JuneBrain firmographics

Firmographics
Name
JuneBrain
Legal name
JuneBrain Inc.
Website
https://junebrain.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
JuneBrain Inc. is a Baltimore-based medical technology company developing portable AI-powered OCT imaging hardware and deep learning segmentation software for remote monitoring of neurological and retinal diseases, serving clinical research organizations, reading centers, and neurology providers.
Ownership category
akta.pro rank

JuneBrain industry classification

Industry
Product category
Ophthalmic Medical Imaging Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAJAB
Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLALAGAC
Neurology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Retinal imaging devices
  • OCT analysis software
  • Neurological disease monitoring
  • AI medical imaging
  • Clinical research OCT

Where JuneBrain is headquartered

Location

Headquarters

HQ city
Baltimore
HQ country
United States
HQ region
North America

Offices2 records

Markets served

JuneBrain business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Software Licensing (JDAe): Annual per-seat license for JDAe automated segmentation software at $6K/year. Customers can test with one free analysis before committing. Pricing is transparent and subscription-based.
  2. Software Licensing (JAM): Annual per-seat license for JAM manual correction tool at $3.5K/year. Can be bundled with JDAe for $8.5K/year.
  3. Bundled Software License: Bundle of both JDAe and JAM tools at $8.5K/year, offering savings of $1K compared to separate purchases.
  4. Neuro-i SS-OCT Device Sales: Hardware sales of the Neuro-i SS-OCT portable retinal imaging device for point-of-care settings. The company is pursuing FDA clearance for early commercial launch.
  5. Reading Center Services: OCT analysis services for clinical research, including both fixed price and subscription options for research groups and reading centers.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualJDAe - Automated segmentation annual license
SubscriptionAnnualJAM - Manual correction annual license
SubscriptionAnnualBundle - Both JDAe and JAM tools

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

JuneBrain product offering

Product offering

Core offering

JuneBrain develops telehealth OCT (Optical Coherence Tomography) devices and AI-powered software for remote monitoring of neurological and retinal diseases. Its flagship product, the Neuro-i SS-OCT, is a portable wearable retinal imaging headset designed for use by minimally trained personnel in neurology, primary care, and community health settings. The company also sells JDAe (automated deep learning segmentation software) and JAM (manual correction tool) on annual per-seat licenses, and provides the Reading Center OCT analysis service for clinical research organizations.

Product overview

JuneBrain develops a telehealth OCT device and AI software platform for remote monitoring of neurological and retinal diseases. The core product is the Neuro-i SS-OCT, a portable wearable retinal imaging headset that enables point-of-care OCT imaging in non-traditional settings. Supporting the hardware is a software portfolio comprising JDAe (AI-driven automated segmentation engine) and JAM (manual correction tool) for analyzing OCT data from multiple device vendors. The Reading Center service provides outsourced quantitative OCT analysis for clinical research. The platform is designed for investigational use only.

Differentiator

Problem solved

Functional benefit

Brands

  • Neuro-i SS-OCT: Wearable AI-powered retinal imaging platform for point-of-care OCT imaging in neurology, primary care, and community health settings.
  • Reading Center

Products and services

  • Neuro-i SS-OCT A portable, wearable AI-powered retinal imaging headset using swept-source OCT technology for point-of-care use in neurology, primary care, and community health settings. Designed for minimally trained users with automated image acquisition.
  • JDAe (JuneBrain Deep Learning Engine) AI-based automated segmentation software that reads Cirrus, Spectralis, and Neuro-i OCT data; segments 8+ retinal layers automatically; measures average thickness for 9 standard ETDRS subfields; and exports deterministic results in PDF report and CSV formats. Licensed annually per seat at $6,000/year.
  • JAM (JuneBrain Annotation Module) Manual correction tool for OCT segmentation that allows users to correct existing layer boundaries, annotate pathological regions, and export corrected data in JSON format. Includes human-in-the-loop QC and full audit trail for trial-grade data. Licensed annually per seat at $3,500/year, or bundled with JDAe at $8,500/year.
  • Reading Center Outsourced quantitative OCT analysis service for clinical research organizations and reading centers. Provides fast, automated deep-learning-based analysis, reliable segmentation of up to 8 retinal layers, quality control by experienced clinicians, and both fixed-price and subscription pricing options.

Companies that use JuneBrain

Customer profile

Segments3 records

Ideal customer profiles3 records

JuneBrain technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature4 records

JuneBrain partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered supporting.

  • Compliance GroupsupportingImplementation/ SI/ Consulting Partner · 8 September 2024Compliance Group collaborated with JuneBrain on the MDIC AMCH program grant to implement advanced design control and risk management technology for quality management system modernization.
  • Siemens Digital IndustriessupportingTechnology or Integration · 8 September 2024Siemens Digital Industries collaborated with JuneBrain on the MDIC AMCH program grant to implement advanced design control and risk management technology, supporting FDA clearance efforts.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

JuneBrain competitors and assessment

Company assessment

Direct peers

  • Heidelberg Engineering: Manufacturer of the Spectralis OCT platform, one of the dominant clinical OCT systems whose data JuneBrain's JDAe reads; a direct peer in retinal imaging hardware and adjacent in OCT analysis software.
  • Carl Zeiss Meditec: Maker of the Cirrus OCT platform, the other dominant OCT system integrated with JDAe; competes with JuneBrain in ophthalmic imaging and increasingly in AI-driven analysis.
  • Optovue (Visionix): Developer of Avanti and Solix OCT/ OCTA devices, a direct peer in retinal OCT hardware pursuing point-of-care and AI-enabled imaging workflows similar to Neuro-i.
  • Topcon Healthcare: Major ophthalmic imaging vendor (Maestro2, Triton OCT) competing in the same OCT hardware category and pushing AI/portable features relevant to JuneBrain's roadmap.
  • Notal Vision: Home-based OCT monitoring service for retinal disease using AI-driven analysis; highly comparable business model to JuneBrain's Reading Center plus Neuro-i concept of remote, frequent retinal monitoring.
  • iCare (Revenio Group): Maker of iCare EIDON and DRI OCT Triton/Atlantis systems, competing in clinical and emerging portable OCT segments and pursuing primary-care adoption analogous to Neuro-i.
  • RetinAI Medical: AI platform for OCT and fundus image analysis used by ophthalmology clinics and clinical research; the closest direct competitor to JDAe/JAM in OCT segmentation SaaS.

Emerging players

  • Voxeleron: Specialist in AI-based OCT layer segmentation and analysis tools for research and clinical use; competes with JuneBrain's JDAe/JAM in the OCT segmentation software category.
  • Mediwhale: AI health-screening company using retinal imaging (including OCT) to predict systemic and neurodegenerative disease risk; overlaps with JuneBrain's MS/neurology use cases via AI-on-retina.

Others

  • Digital Diagnostics: FDA-cleared autonomous AI diagnostic platform (IDx-DR) for diabetic retinopathy; comparable as a regulated AI-imaging diagnostics company navigating similar regulatory and clinical-adoption dynamics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

JuneBrain social profiles

Digital presence

JuneBrain compliance and trust

Trust signal

Compliance2 records

JuneBrain financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JuneBrain leadership team

Management profile

Number of profiles

Profiles1 record

JuneBrain funding detail

Funding detail

Funding overview

Funding rounds13 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JuneBrain M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JuneBrain

What does JuneBrain do?

JuneBrain develops telehealth OCT (Optical Coherence Tomography) devices and AI-powered software for remote monitoring of neurological and retinal diseases. Its flagship product, the Neuro-i SS-OCT, is a portable wearable retinal imaging headset designed for use by minimally trained personnel in neurology, primary care, and community health settings. The company also sells JDAe (automated deep learning segmentation software) and JAM (manual correction tool) on annual per-seat licenses, and provides the Reading Center OCT analysis service for clinical research organizations.

Is JuneBrain a public or private company?

JuneBrain is a private company. It is classified as venture growth investor backed and is currently operating.

When was JuneBrain founded?

JuneBrain was founded in 2017. It employs 11 to 50 people.

Where is JuneBrain based?

JuneBrain is headquartered in Baltimore, United States, in the North America region.

How does JuneBrain make money?

Five revenue lines are on record. Software Licensing (JDAe) is the primary driver. The others are software Licensing (JAM), bundled Software License, neuro-i SS-OCT Device Sales and reading Center Services.

Who are JuneBrain's main competitors?

Direct peers on record are Heidelberg Engineering, Carl Zeiss Meditec, Optovue (Visionix), Topcon Healthcare, Notal Vision, iCare (Revenio Group) and RetinAI Medical. Emerging players are Voxeleron and Mediwhale. Digital Diagnostics is listed as an others.

Does JuneBrain have an API?

No public API is recorded for JuneBrain.

What industry is JuneBrain in?

JuneBrain's product category is Ophthalmic Medical Imaging Software. Its primary akta.pro industry code is HLAHAJAB, Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography), with a secondary code of HLALAGAC, Neurology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechnicalBaltimore startup JuneBrain brings its eye and brain scanning tech to Louisiana clinicsJuneBrain, a Baltimore biotech startup, is launching a 30-day pilot in New Orleans eye clinics to use AI retinal imaging for early detection of eye and neurological diseases. The company is raising $5 million in a pre-FDA clearance round and plans to seek FDA clearance by next year.citybizTEDCO-Backed JuneBrain Attracts Investment From New Orleans Fund, Gulf South AngelsTEDCO-backed JuneBrain has secured joint investment from The New Orleans BioFund and Gulf South Angels to expand its AI-powered retinal imaging technology into Louisiana and deepen clinical partnerships with regional health systems and universities. The Baltimore-based startup will use the funding to scale its optical coherence tomography (OCT) platform for remote monitoring of neurological diseases including multiple sclerosis, Parkinson's, and Alzheimer's. JuneBrain previously won first place in the New Orleans BioInnovation Center's BioChallenge pitch competition and received a $250,000 investment from TEDCO last October.National TodayJuneBrain secures investment for neurotech expansionNeurotech startup JuneBrain secured a joint investment from The New Orleans BioFund and Gulf South Angels, announced on April 3, 2026, to advance its AI-powered headset technology for remotely monitoring neurological conditions such as multiple sclerosis, Parkinson's, and Alzheimer's disease. The funding will support product development, expand access to the technology, and deepen partnerships with healthcare systems and universities across Louisiana. The company previously placed first in the 2025 BioChallenge Pitch Competition, and this investment is intended to accelerate growth within Louisiana's life sciences ecosystem.New Orleans City BusinessJuneBrain secures investment for neurotech expansionJuneBrain has secured new investment funding to expand its neurotechnology operations. The article highlights the company's focus on advancing its neurotech solutions with the new capital. No future developments are specified.citybizETC Invests in Baltimore MedTech Startup JuneBrainEmerging Technology Centers (ETC) Baltimore announced a $200,000 co-investment in JuneBrain as part of the medtech startup's Seed+ funding round, welcoming the company as its newest portfolio company. JuneBrain, founded in 2017 and headquartered at The LaunchPort in Baltimore City, has developed the Neuro-i SS-OCT, a wearable AI-powered retinal imaging platform designed to expand high-resolution OCT imaging beyond traditional eye clinics into neurology, primary care, and community health settings. The investment will support JuneBrain's path toward FDA clearance and early commercial launch while positioning the technology to expand access to advanced diagnostics in Baltimore communities.Biz New OrleansJuneBrain Wins NOBIC 2025 BioChallengeJuneBrain Inc. was named the first-place and crowd-favorite winner of the 2025 BioChallenge Pitch Competition, held on October 30 at the New Orleans BioInnovation Center (NOBIC). The Baltimore-based startup develops an AI-powered retinal imaging platform for detecting neuroinflammation and is now seeking partnerships to pilot its diagnostic technology. Origami Therapeutics and Centron Bio secured second and third places respectively in the competition, which features emerging biotech ventures.NbcuacademyThis Eye-Scanning Headset Could Help Detect Disease EarlyJuneBrain is developing the Neuro-i, a portable headset that performs optical coherence tomography scans to detect early signs of diseases such as Alzheimer's, Parkinson's, and heart disease. The device aims to address the gap in OCT imaging equipment among U.S. optometrists by enabling point-of-care diagnostics.SecSEC FORM DJuneBrain Inc., a technology company headquartered in Baltimore, Delaware, filed a Form D notice with the SEC on October 8, 2025, for an exempt offering of equity securities under Rule 506(b). The company is seeking to raise up to $3,000,000 and has already sold $450,000 to one investor, leaving $2,550,000 remaining to be sold, with the first sale occurring on September 17, 2025. This is a routine regulatory filing required when issuers claim an exemption from securities registration requirements.BizmonthlyTEDCO invests in JuneBrainTEDCO has invested $200,000 from its Builder Fund into JuneBrain, a Baltimore-based biotechnology company focusing on ophthalmology and neurology. JuneBrain develops investigational products including a retinal imaging system and AI software for analyzing neurodegenerative diseases. This investment continues TEDCO's support of the company, which previously received funding through the Pre-Seed Builder Fund and State Small Business Credit Initiative.